Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback